Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

A Case of Capmatinib used in MET Amplification Glioblastoma

Author:Boldig, Catherine   Mokhtari, Sepideh   

Session Name:P9: Neuro-oncology: Cases in Neuro-oncology  

Topic:Neuro-oncology  

Program Number:P9.001  

Author Institution:USF, Tampa, FL  Moffitt Cancer Center, Tampa, FL  

Neurological Complications of Immune Checkpoint Inhibitors

Author:Poovathukaran Babu, Abida   Sharda, Esha   Kolli, Avinash   Mora-Rodriguez, Karla   Boldig, Catherine   Gatewood, Tyra   Shah, Anand   Swank, Jennifer   Pina, Yolanda   Peguero, Edwin   Jaffer, Muhammad   Mokhtari, Sepideh   Verma, Neha   

Session Name:P12: Neuro-oncology: Neurologic Complications of Cancer  

Topic:Neuro-oncology  

Program Number:P12.004  

Author Institution:University of South Florida, Tampa, FL  Moffitt Cancer Center, Tampa, FL, FL  USF-Morsani, Tampa, FL  Univeristy of South Florida, Tampa, FL  Moffitt Cancer Center, Tampa, FL  Moffitt Cancer Center, Tampa, FL , FL  

Maraviroc pharmacotherapy in post-stroke depression: A proof of concept clinical trial

Author:Ben Assayag, Einor   Tene, Oren   Molad, Jeremy   Seyman, Estelle   Rotschild, Ofer   Hallevi, Hen   

Session Name:S20: Cerebrovascular Disease and Interventional Neurology: Clinical Trials and Outcomes Studies  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S20.004  

Author Institution:Tel Aviv Sourasky Medical Center, Tel Aviv, Israel  

Characterization of Childhood Neurodegeneration and Associated Ataxia in UBTF-Related Disorder

Author:Nagy, Amanda   Luddy, Anna   Molay, Francine   De La Rosa Abreu, Lizbeth   Becker, Catherine   Gupta, Anoopum   Eichler, Florian   

Session Name:P12: Child Neurology and Developmental Neurology: Autoimmune Encephalitides/Demyelinating Disorders/Infections  

Topic:Child Neurology and Developmental Neurology  

Program Number:P12.011  

Author Institution:Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, Brigham, Harvard, Boston, MA  

Treatment at Onset Predicts a Longer Time-to-Relapse After Index Event in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Author:Molazadeh, Negar   Bilodeau, Philippe-Antoine   Salky, Rebecca   Bose, Gauruv   Chitnis, Tanuja   Levy, Michael   

Session Name:S40: Autoimmune Neurology: Stiff Person Syndrome/GAD65 Neurological Autoimmunity, CIDP, and MOGAD  

Topic:Autoimmune Neurology  

Program Number:S40.009  

Author Institution:Massachusetts General Hospital and Harvard Medical School, Charlestown , MA  Massachusetts General Hospital and Harvard Medical School, Boston, MA  Massachusetts General Hospital and Harvard Medical School, Cambridge, MA  Brigham MS Center, Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA Harvard Medical School and Division of Neurology, Department of Medicine, The Ottawa Hospital and University of Ottawa  Ottawa Hospital Research Institute, ON, Canad, Boston, MA  Brigham and Women's Hospital, Boston, MA